ESC 365 - Anti-mmu-mir-721 as a therapeutic target for immune checkpoint inhibitor-associated myocarditis

Delegates Premium Access

Anti-mmu-mir-721 as a therapeutic target for immune checkpoint inhibitor-associated myocarditis

Session: Young Investigator Award - Basic and Translational Research

Topic: Research and New Technology

Speaker: Mr E. Ortega Sollero (Madrid, ES)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Mr Enrique Ortega Sollero

Madrid (Spain)

0 follower

2 more presentations in this session

Targeting FPR1 to prevent doxorubicin-induced cardiomyopathy

Speaker: Assistant Professor L. Schirone (Rome, IT)

Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies

Speaker: Miss A. Strijdhorst (Amsterdam, NL)

Access the full session

Young Investigator Award - Basic and Translational Research

Speakers: Mr E. Ortega Sollero, Assistant Professor L. Schirone, Miss A. Strijdhorst

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources